Source: International Congress 2017 – Molecular pathways in lung development



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ren (Los Angeles, United States of America). Mesenchymal Tsc2 deficiency causes retarded lung alveolarization and polycystic kidney lesion. 2084

Member's Comments

No comment yet.

Related content which might interest you: Mesenchymal Tsc2 deficiency causes retarded lung alveolarization and polycystic kidney lesion Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Lipogenic switch of fibroblast to lipofibroblast induce lung regeneration in a model of bronchopulmonary dysplasia Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 Mesenchymal stem cells from adipose tissue reduce bleomycin-induced lung remodeling in late stage Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 The role of vascular endothelial growth factor D in diagnosis of polycystic lung diseases Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Mesenchymal stem cells and fibrotic lung diseases Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 Dasatinib suppresses TGFbeta-induced epithelial mesenchymal transition and inhibits pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling? Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Pro-fibrotic phenotype of human Hermansky-Pudlak syndrome lung fibroblasts Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021